Cutaneous side effects in a cohort of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: General description and further characterization, correlation with photoexposition and study of hypopigmentation as treatment's prognostic factor

  1. Llamas-Velasco, M.
  2. Ovejero-Merino, E.
  3. García-Diez, A.
  4. Requena, L.
  5. Daudén, E.
  6. Steegmann, J.L.
Revista:
Dermatologic Therapy

ISSN: 1529-8019,  1396-0296

Año de publicación: 2020

Volumen: 33

Número: 6

Tipo: Artículo

DOI: 10.1111/DTH.14428 GOOGLE SCHOLAR lock_openAcceso abierto editor
Fuente de los datos: Scopus